Triavil

People who are taking antidepressant drugs known as MAO inhibitors (including Nardil and Parnate) should not take Triavil.

Special warnings about Triavil

In clinical studies, antidepressants increased the risk of suicidal thinking and behavior in children and adolescents with depression and other psychiatric disorders. Anyone considering the use of Triavil or any other antidepressant in a child or adolescent must balance this risk with the clinical need. Triavil is not approved for use in children.

Additionally, the progression of major depression is associated with a worsening of symptoms and/or the emergence of suicidal thinking or behavior in both adults and children, whether or not they are taking antidepressants. Individuals being treated with Triavil and their caregivers should watch for any change in symptoms or any new symptoms that appear suddenly--especially agitation, anxiety, hostility, panic, restlessness, extreme hyperactivity, and suicidal thinking or behavior--and report them to the doctor immediately. Be especially observant at the beginning of treatment or whenever there is a change in dose.

Before using Triavil, tell your doctor if you have ever had the following: glaucoma (high pressure in the eye); difficulty urinating; breast cancer; breathing problems; seizures; heart, liver, kidney, or thyroid disease; or if you are exposed to extreme heat or pesticides. Be aware that Triavil may mask signs of brain tumor, intestinal blockage, and overdose of other drugs.

Nausea, headache, and a general ill feeling can result if you suddenly stop taking Triavil. Follow your doctor's instructions closely when discontinuing Triavil. If your dose is gradually reduced, you may experience irritability, restlessness, and dream and sleep disturbances, but these effects will not last.

This drug may impair your ability to drive a car or operate potentially dangerous machinery. Do not participate in any activities that require full alertness if you are unsure about your ability.